The Efficacy of vitamin D in treating patients with nasal congestio
Phase 3
Recruiting
- Conditions
- Allergic rhinitis.Allergic rhinitis, unspecified
- Registration Number
- IRCT20180217038763N2
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Patients with allergic rhinitis
Conscious Consent
Exclusion Criteria
Use of other drugs in addition to prescription drugs
Having vitamin D deficiency
Pregnant and infected people with immunodeficiency and skin diseases
Having allergies to prescription drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms of Allergic rhinitis. Timepoint: At the beginning of the study, and weeks 4 and 8, after starting taking vitamin D. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method